Effects of acetylcholine and of agents that mimic or block its physiological actions have been studied upon concentrations of guanosine 3':5'-cyclic monophosphate (cyclic GMP) and adenosine 3':5'-cyclic monophosphate (cyclic AMP) in slices of mammalian cerebral cortex, heart ventricle, and ileum. Acetylcholine, and cholinomimetic agents with a predominantly muscarinic action, such as methacholine, bethanechol, and pilocarpine, induced an increase in the concentration of cyclic GMP, accompanied by no change or a slight decrease in the concentration of cyclic AMP, in all three tissues studied. Tetramethylammonium, a cholinomimetic agent with a predominantly nicotinic action, on the other hand, did not significantly alter concentrations of either cyclic GMP or cyclic AMP. The increase in the tissue content of cyclic GMP induced by acetylcholine and its muscarinic analogs was antagonized by atropine, a muscarinic blocking agent, but not by hexamethonium, a nicotinic blocking agent.
heart ventricle, and ileum. Acetylcholine, and cholinomimetic agents with a predominantly muscarinic action, such as methacholine, bethanechol, and pilocarpine, induced an increase in the concentration of cyclic GMP, accompanied by no change or a slight decrease in the concentration of cyclic AMP, in all three tissues studied. Tetramethylammonium, a cholinomimetic agent with a predominantly nicotinic action, on the other hand, did not significantly alter concentrations of either cyclic GMP or cyclic AMP. The increase in the tissue content of cyclic GMP induced by acetylcholine and its muscarinic analogs was antagonized by atropine, a muscarinic blocking agent, but not by hexamethonium, a nicotinic blocking agent.
These and other results suggest the generalization that the interaction of acetylcholine with muscarinic receptors, but not with nicotinic receptors, causes an increase in the concentration of cyclic GMP. The data are compatible with the hypothesis that cyclic GMP may mediate the muscarinic actions of acetyicholine.
The antagonistic actions of cholinergic and adrenergic agents on the physiology of contraction of intestinal smooth muscle and of cardiac muscle are reflected in, and may result from, antagonistic actions of these compounds on the levels of both cyclic GMP and cyclic AMP in these tissues.
A substantial amount of evidence now exists indicating that several hormones and neurotransmitter agents may exert their biological actions by altering the amount of adenosine 3':5'-monophosphate (cyclic AMP) in target cells. In recent years, the possibility has been raised that guanosine 3':5'-cyclic monophosphate (cyclic GMP) may also play a significant role in the regulation of metabolism and function in animal tissues. Cyclic GMP has been found in tissues and fluids of several species (e.g., [1] [2] [3] [4] , and enzymes have been found that catalyze the synthesis (4, 5) and breakdown (6) of cyclic GMP. In addition, a family of protein kinases has been found that is specifically activated by cyclic GMP (7) (8) (9) , rather than by cyclic AMP, and it has been proposed (7) that the biological effects of cyclic GMP are mediated through this family of protein kinases (7) (8) (9) . Nevertheless, little is known about the factors that regulate the concentration of cyclic GMP in tissues or about the nature of the biological effects that may be regulated by cyclic GMP.
Recent studies indicate that acetylcholine can cause the accumulation of cyclic GMP in heart (10, 11), brain (11, 12) , and ductus deferens (13) . Perfusion of isolated rat heart with acetylcholine caused an increase of up to 140% in cyclic GMP content (10) . Moreover, application of low concentrations of acetylcholine to slices of rat heart caused increases of up to 10-fold in the concentration of cyclic GMP (11) . The amount of cyclic GMP in brains of rats was increased up to 80% (12) by the injection of oxotremorine, an agent known to affect cholinergic mechanisms in the nervous system. The application of acetylcholine to slices of rabbit cerebellum or cerebral cortex increased the cyclic GMP concentration by up to 3.5-fold (11) .
There are two classes of acetylcholine receptors, designated muscarinic and nicotinic. These two classes of receptors have distinct anatomical distributions and physiological functions. They can be distinguished from one another by drugs that either mimic or antagonize the various actions of acetylcholine. It seemed of considerable importance to determine whether the effects of acetylcholine on the concentrations of cyclic nucleotides are characteristic of one or the other or both types of acetylcholine receptor. In the present study, the effect of acetylcholine, and of related agonists and antagonists, on concentrations of cyclic GMP and cyclic AMP has been studied in several types of mammalian tissue. The data indicate that the increase in the amount of cyclic GMP brought about by acetylcholine is attributable to its interaction with muscarinic, rather than with nicotinic, receptors in these tissues.
MATERIALS AND METHODS
Cyclic GMP-dependent protein kinase from pupal fat body from cecropia silkmoth (8) and cyclic AMP-dependent protein kinase from bovine heart (14) were purified through the step of ammonium sulfate precipitation and DEAE-cellulose column chromatography, respectively. The fat body from silkmoth pupae was generously provided by Dr. G. R. Wyatt of the Department of Biology. Acetylcholine, bethanechol, methacholine, pilocarpine, tetramethylammonium, atropine, hexamethonium, tubocurarine, and isoproterenol were purchased from Sigma. Other materials used in the present study were the same as described in ref. 11. Preparation and Incubation of Tissue Slices. Preparation and incubation of slices of rabbit cerebral cortex (11) and of rat-heart ventricle (11, 15) were as described. Tissues were incubated for periods of time found to cause maximal increases in cyclic GMP content. These periods were 3 min for slices of cerebral cortex (11) (11, 17) , assay for cyclic GMP (11) with cyclic GMPdependent protein kinase from silkmoth fat body, and assay for cyclic AMP (17) with cyclic AMP-dependent protein kinase from bovine heart were as described.
RESULTS

Rabbit cerebral cortex
An increase in the concentration of cyclic GMP in slices of rabbit cerebral cortex, upon incubation in the presence of ** Not significantly different from bethanechol alone. Conditions were the same as described in Table 2 , except for the indicated additions.
* Isoproterenol significantly increased the amount of cyclic AMP in the absence or presence of atropine (P < 0.01).
t Significantly different from isoproterenol in the absence of atropine (P < 0.01).
t Not significantly different from isoproterenol in the presence of atropine.
acetylcholine, is shown in Table 1 . This increase in the cyclic GMP content of cerebral cortical slices was also observed in the presence of each of the muscarinic agonists tested, namely, bethanechol, methacholine, and pilocarpine. In contrast, the nicotinic agonist tetramethylammonium did not cause a significant increase in the concentration of cyclic GMP. The increase in cyclic GMP content observed in the presence of the muscarinic agonists was abolished by low concentrations of atropine, the muscarinic antagonist, but not by even high concentrations of hexamethonium, the nicotinic antagonist (Table 1) . No significant change in cyclic AMP content was observed with any of the agonists or antagonists tested.
Rat-heart ventricle
As in the case of the studies on cerebral cortex, we found that acetylcholine (Table 2 ) and the muscarinic agonists, namely pilocarpine, bethanechol (Table 2) , and methacholine, each increased the concentration of cyclic GMP in slices of ratheart ventricle, whereas the nicotinic agonist tetramethylammonium was ineffective. A low concentration of atropine prevented the increase in concentration of cyclic GMP brought about by acetylcholine or the muscarinic agonists, whereas hexamethonium and tubocurarine, the two nicotinic antagonists tested, were not effective in this regard. Little or no change was observed in the concentration of cyclic AMP in heart slices in the experiments of Table 2 .
Acetylcholine has been found to diminish the increase in the concentration of cyclic AMP brought about by isoproterenol in heart slices (15) . In the present study, we showed that the ability of acetylcholine to lower cyclic AMP content, like its ability to raise cyclic GMP content, was blocked by a low concentration of atropine (Table 3) .
Guinea-pig ileum
The effect of incubation in the presence of acetylcholine, for various periods of time, on the cyclic GMP content of the ileal muscularis is shown in Fig. 1 . Acetylcholine caused an increase in cyclic GMP content within 10 sec, the earliest time studied. This response was sufficiently rapid that it could account for the ability of acetylcholine to induce contraction of this smooth muscle: several seconds were required, after application of acetylcholine, until the contraction of this smooth muscle could be observed, and about 30 sec was required for maximal contraction.
The effect of various concentrations of acetylcholine and of the muscarinic agonist, bethanechol, on cyclic GMP content in the ileum are shown in Table 4 . The greater apparent effect of bethanechol than of acetylcholine, at the lowest concentration tested, may be attributable to the fact that bethanechol is resistant to hydrolysis by acetylcholinesterase. In contrast to the effect of bethanechol, tetramethylammonium did not increase cyclic GMP content of ileal musculature (Table 4) . As in the case of the experiments with brain and heart, the increase in the concentration of cyclic GMP in guinea-pig ileum, brought about by acetylcholine or the muscarinic agonists, was prevented by atropine but not by hexamethonium (Table 4 (Tables 5 and 6 ). The increase in cyclic GMP brought about by bethanechol could be prevented by the inclusion of isoproterenol in the incubation medium (Table 5) . Isoproterenol also lowered the endogenous concentration of cyclic GMP slightly, but this effect was not statistically significant. Conversely, isoproterenol caused an increase in the concentration of cyclic AMP in the' guinea-pig ileum that could be partially prevented by bethanechol (Table 6 ). This action of bethanechol could be blocked by a low concentration of atropine, indicating that the effect of bethanechol on cyclic Each value represents the mean 4-SEM of assays on three tissue samples, each of which was analyzed in triplicate. Cyclic GMP content, at all incubation times studied, was significantly different from the zero-time control (P < 0.05). t Significantly different from the control (P < 0.05).
1 Significantly different from the control (P < 0.01). § Significantly different from bethanechol alone ( P < 0.01). ¶ Not significantly different from bethanechol alone.
AMP content, as well as that on cyclic GMP content, was mediated through muscarinic receptors. In some ileal preparations, a decrease in endogenous cyclic AMP content oc- Slices of longitudinal muscle were incubated for 2 min in the presence of the indicated agents. Other conditions were the same as described in Table 4 .
* Isoproterenol significantly increased cyclic AMP content in the absence and presence of atropine (P < 0.01).
t Not significantly different from isoproterenol in the presence of atropine. curred in response to acetylcholine or bethanechol; this effect of the cholinergic agonists was also blocked by atropine. DISCUSSION There is a striking similarity between intestinal smooth muscle and cardiac muscle with respect to the effect of cholinergic and adrenergic agents on cyclic nucleotide content. In cardiac muscle, cyclic GMP content was increased by acetylcholine, and this increase was prevented by isoproterenol (11); similar results were obtained with intestinal smooth muscle (Table 5) . Conversely, in both cardiac muscle (ref. 11; Table 3 ) and intestinal smooth muscle (Table 6) , cyclic AMP content was increased by isoproterenol, and this increase was prevented by acetylcholine or bethanechol. A reasonable hypothesis, consistent with these data, is that the physiological effects of cholinergic and adrenergic agents on cardiac and intestinal smooth muscle are mediated through regulation of the relative concentrations of cyclic GMP and cyclic AMP. Thus, cholinergic effects would be mediated through a high cyclic GMP/cyclic AMP ratio and adrenergic effects would be mediated through a high cyclic AMP/cyclic GMP ratio in these tissues.
The present studies indicate that, at least in brain, heart muscle, and intestinal smooth muscle, the increase in concentration of cyclic GMP observed in response to acetylcholine is mediated by muscarinic, rather than by nicotinic, receptors. Mammalian brain contains both muscarinic and nicotinic receptors. In heart and intestinal smooth muscle, the physiological responses to acetylcholine appear to be mediated solely by muscarinic receptors. 
